LARITUM SB

laritum-sb-inj-new

Composition

Laritum SB – ceftriaxone 1g + Sulbactam 500 mg injection (intravenous route/intramuscular route of administration)
Mode of action
Ceftriaxone – 3rd generation ceplalosporin, Inhibit bacterial cell wall synthesis
Sulbactam – Beta lactamase inhibitor
Indication
Acute Bacterial Otitis Media, Prosthetic Joint Infection, Pyelonephritis, Surgical Prophylaxis, Meningitis, Skin and Soft Necrotizing Infection, Pelvic inflammatory disease, Endometritis, Gonorrhea, Intra abdominal infection, Severe Acute Bacterial Rhinosinusitis, urinary tract infection, Respiratory tract infection, Bone and joint infection
Dosage – 1 to 2gm per day in divided doses(every 12 hrs)
Contraindications – clotting disorder, low vitamin K, liver disease
Side effect – chest pain, sore throat, weakness
Adverse Drug Reaction – shortness of breath, hives, hoarseness
Drug interaction – enoxaparin, BCG vaccine, heparin